July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Altered Focal-adhesion Pathway Gene Expression Pattern in iPSC-derived RPE Cells derived from AMD Patients
Author Affiliations & Notes
  • Huey Cai
    Ophthalmology, Yale School of Medicine, New Haven, New York, United States
  • Jie Gong
    Ophthalmology, Yale School of Medicine, New Haven, New York, United States
  • Lucian V Del Priore
    Ophthalmology, Yale School of Medicine, New Haven, New York, United States
  • Mark Anthony Fields
    Ophthalmology, Yale School of Medicine, New Haven, New York, United States
  • Footnotes
    Commercial Relationships   Huey Cai, None; Jie Gong, None; Lucian Del Priore, None; Mark Fields, None
  • Footnotes
    Support  Research to Prevent Blindness; Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1225. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Huey Cai, Jie Gong, Lucian V Del Priore, Mark Anthony Fields; Altered Focal-adhesion Pathway Gene Expression Pattern in iPSC-derived RPE Cells derived from AMD Patients. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1225. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Induced pluripotent stem cell-derived retinal pigment epithelial cells (iPSC-derived RPE) have been investigated for use as a source for cell replacement in geographic atrophy. Here, we conducted a characterization study on iPSC-derived RPE cells from age-related macular degeneration (AMD) patients as well as from age-matched individuals with no history of AMD.

Methods : Human iPSCs were generated from fibroblasts of 6 donors with atrophic AMD (4 donors) or 2 age-matched controls with no history of AMD by treating with reprogramming factors, Oct3/4, Sox-2, Klf4, and c-Myc method. Derived RPE cells were generated by culturing with RPE differentiation medium using established protocols. Immunocytochemistry, transepithelial electrical resistance (TEER) of monolayers, and phagocytosis were used to characterize iPSC-derived RPE cells. DNA microarray was used to observe the gene expression profile of all six lines of iPSC-derived RPE cells.

Results : Morphology, immunocytochemistry, phagocytosis and TEER assays revealed characteristics of native RPE cells. The gene expression levels of a majority of the 22000 annotated genes were similar when comparing AMD vs. non-diseased donor derived iPSC-RPE cells. However, principal components analysis (PCA) and hierarchical clustering analysis in DNA Microarray study clearly differentiate RPE cells from AMD patients apart from those of non-diseased individuals. Moreover, gene expression profile analysis reveals changes in expression levels for 700 genes of 22,000 probes tested (3.1%) when comparing AMD iPSC-RPE cells to non-diseased donors. These altered genes are involved in many different metabolic and signal transduction pathways. Among the altered genes in RPE cells from AMD patients, the focal adhesion-PI3K-Akt-mTOR-signaling pathway ranked first in the number of genes involved and their statistical significance.

Conclusions : Although iPSC-derived RPE cell characteristics are similar between AMD and non-diseased donors, there are distinct differences in gene expression profile between these 2 populations. The significance of these changes for the utilization of patient-specific RPE to treat geographic atrophy remains to be elucidated.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×